|(C;C)||0||common in clinvar|
[PMID 15122513] Fibroblast growth factor 20 polymorphisms and haplotypes strongly influence risk of Parkinson disease.
[PMID 15967032] Lack of evidence for a genetic association between FGF20 and Parkinson's disease in Finnish and Greek patients.
[PMID 18252210] Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein.
[PMID 19133659] FGF20 and Parkinson's disease: no evidence of association or pathogenicity via alpha-synuclein expression.
[PMID 19290790] MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine.
[PMID 20427658] Genetic variation in FGF20 modulates hippocampal biology.
[PMID 20428464] MicroRNA polymorphisms: a giant leap towards personalized medicine.
[PMID 22342445] Fibroblast growth factor 20 (FGF20) polymorphism is a risk factor for Parkinson's disease in Chinese population.
[PMID 23516905] [Analysis of the rs12720208 single-nucleotide polymorphism of the FGF20 gene in Russian patients with sporadic Parkinson's disease]
[PMID 23938014] Fibroblast growth factor 20 polymorphism in sporadic Parkinson's disease in Northern Han Chinese
[PMID 26070653] Variation in the miRNA-433 binding site of FGF20 is a risk factor for Parkinson's disease in Iranian population
|CLNDBN||Parkinson disease, late-onset|
|CLNSRC||OMIM Allelic Variant|